According to updated guidance from the National Institute of Health and Care Excellence (NICE), hormone replacement therapy (HRT) neither shortens nor extends life expectancy for women managing menopause symptoms. The analysis reveals that while there are certain health risks associated with HRT, including a slight increase in breast cancer risk, these do not translate into changes in overall lifespan. NICE emphasizes the importance of personalized patient discussions to help women make informed treatment choices, also suggesting that talking therapy may complement HRT for enhanced symptom management.